Pharmaceutical Executive

Pharmaceutical Executive Podcast
  • 4,0 (1)
  • SCIENCE DE LA VIE
  • TOUS LES MOIS
Pharmaceutical Executive

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

  1. Key Findings of the NIAGARA and HIMALAYA Trials

    8 NOV.

    Key Findings of the NIAGARA and HIMALAYA Trials

    In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.

    13 min
  2. Fake Weight Loss Drugs: Growing Threat to Consumer Health

    25 OCT.

    Fake Weight Loss Drugs: Growing Threat to Consumer Health

    UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss: Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks What can be done to raise awareness among consumers about the dangers of counterfeit medications Ways increase access to legitimate weight loss medications, especially for those in underserved communities and much more!

    21 min
  3. A Different Approach to Dermatology Care

    23 SEPT.

    A Different Approach to Dermatology Care

    Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.

    15 min
  4. Beyond the Birthrate: The Societal Costs of Maternal Morality

    6 SEPT.

    Beyond the Birthrate: The Societal Costs of Maternal Morality

    In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses: The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical areas of need in maternal health How her in-practice experience as an OB-GYN are informing Organon's strategic approach to addressing maternal health challenges and more!

    16 min
  5. Empty Shelves, Urgent Solutions

    5 AOÛT

    Empty Shelves, Urgent Solutions

    Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of both large and independent pharmacies, what alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities), some potential long term consequences if these pharmacy closures continue, and so much more

    19 min
  6. The Weight-Loss Gold Rush: Legal and Regulatory Implications

    11 JUIL.

    The Weight-Loss Gold Rush: Legal and Regulatory Implications

    Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.

    17 min
  7. Healthcare Marketing Strategies for Reaching Diverse Audiences

    14 MAI

    Healthcare Marketing Strategies for Reaching Diverse Audiences

    Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more. Link to Honeycomb Health video: https://www.pharmexec.com/view/going-beyond-visuals-to-connect-with-diverse-audiences

    13 min
  8. A Decade in the Anti-Obesity Arena

    30 AVR.

    A Decade in the Anti-Obesity Arena

    Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.

    23 min
Tout afficher (173)

À propos

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

Informations

  • Création
    Pharmaceutical Executive Podcast
  • Années d’activité
    2018 - 2024
  • Épisodes
    173
  • Classification
    Tous publics
  • Site web de l’émission
    Pharmaceutical Executive

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada